日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Standard-of-care vs expert-recommended discharge destinations for geriatric surgical inpatients: a prospective observational cohort study

老年外科住院患者的标准治疗与专家推荐出院去向:一项前瞻性观察队列研究

Leinert, Christoph; Brefka, Simone; Fotteler, Marina L; Mueller-Stierlin, Annabel S; Gebhard, Florian; Rahbari, Nuh; Bolenz, Christian; Kestler, Hans; Dallmeier, Dhayana; Denkinger, Michael; Kocar, Thomas D

Validation of the Charité Mobility assessment (CHARMI) in older adults across a wide range of functional levels - the prospective longitudinal MobiTest cohort study

验证夏里特行动能力评估(CHARMI)在不同功能水平老年人群中的有效性——前瞻性纵向MobiTest队列研究

Kroboth, Lea; Verri, Filippo Maria; Haug, Vanessa; Fleiner, Tim; Böhm, Felix; Liebl, Max E; Denkinger, Michael; Leinert, Christoph

Age-dependent differences in survival of patients with early breast cancer: analysis of SUCCESS A, B, C trials

早期乳腺癌患者生存率的年龄依赖性差异:SUCCESS A、B、C 试验分析

Lukac, Stefan; Dayan, Davut; Janni, Wolfgang; Rack, Brigitte; Fink, Visnja; Veselinovic, Kristina; Pfister, Kerstin; Fink, Angelina; Friedl, Thomas W P; Leinert, Elena

Identifying Key Predictors of Appropriate Discharge Destinations for Older Inpatients in Acute Care: Scoping Review

确定老年急性住院患者出院去向的关键预测因素:范围界定综述

Leinert, Christoph; Fotteler, Marina Liselotte; Kocar, Thomas Derya; Wolf, Jessica; Beissel, Lisa; Grummich, Kathrin; Dallmeier, Dhayana; Denkinger, Michael

Companionship at hospital discharge and its association with subsequent delirium onset in older adults - the TRADE observational study

出院时的陪伴及其与老年人随后发生谵妄的关系——TRADE观察性研究

Brefka, Simone; Adamo, Judith; Leinert, Christoph; Braisch, Johanna; Decker, Genia; Muche, Rainer; Seufferlein, Thomas; Klaus, Jochen; Schulte-Kemna, Lena; Eschweiler, Gerhard; Gebhard, Florian; Schuetze, Konrad; Geisler, Tobias; Bahrmann, Anke; Katus, Hugo A; Frey, Norbert; Denninger, Natascha-Elisabeth; Müller, Martin; Pahmeier, Kathrin; Biermann-Stallwitz, Janine; Wasem, Juergen; Flagmeier, Anna Lena; Benzinger, Petra; Bauer, Juergen; Denkinger, Michael; Dallmeier, Dhayana

Detection of adverse events in older adults undergoing surgery using the IHI global trigger tool within the SURGE-Ahead project

在 SURGE-Ahead 项目中,利用 IHI 全球触发工具检测老年手术患者的不良事件

Wolf, Jessica; Verri, Filippo Maria; Kocar, Thomas D; Dallmeier, Dhayana; Cintean, Raffael; Gebhard, Florian; Bolenz, Christian; Rahbari, Nuh; Mueller-Stierlin, Annabel S; Denkinger, Michael; Leinert, Christoph

SURGE-ahead postoperative delirium prediction: external validation and open-source library

SURGE-ahead 术后谵妄预测:外部验证和开源库

Kocar, Thomas Derya; Wolf, Philip; Leinert, Christoph; Brefka, Simone; Fotteler, Marina L; Uihlein, Adriane; Wezel, Felix; Wehling, Martin; Rahbari, Nuh; Kestler, Hans; Gebhard, Florian; Dallmeier, Dhayana; Denkinger, Michael

Calculating Future 10-Year Breast Cancer Risks in Risk-Adapted Surveillance: A Method Comparison and Application in Clinical Practice

基于风险适应性监测的未来10年乳腺癌风险计算:方法比较及临床应用

Zachariae, Silke; Quante, Anne S; Kiechle, Marion; Rhiem, Kerstin; Fehm, Tanja N; Schröder, Jörg-Gunther; Horvath, Judit; Leinert, Elena; Dikow, Nicola; Ronez, Joelle; Schönfeld, Mirjam; van Mackelenbergh, Marion T; Schatz, Ulrich A; Meisel, Cornelia; Aktas, Bahriye; Witt, Dennis; Mehraein, Yasmin; Weber, Bernhard H F; Solbach, Christine; Speiser, Dorothee; Hoyer, Juliane; Faigle-Krehl, Gesine; Much, Christiane D; Müller-Rausch, Alma-Verena; Villavicencio-Lorini, Pablo; Banys-Paluchowski, Maggie; Pieh, Daniel; Schmutzler, Rita K; Fischer, Christine; Engel, Christoph

Correction: Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?

更正:早期激素受体阳性 HER2 阴性乳腺癌的辅助靶向治疗:奥拉帕尼、阿贝西利或瑞博西尼——哪种、如何使用以及适用于哪些人群?

Lukac, Stefan; Pfister, Kerstin; Schäffler, Henning; Leinert, Elena; Fink, Angelina; Rack, Brigitte; Fink, Visnja; Janni, Wolfgang; Heublein, Sabine

Adjuvant Targeted Treatment of Early Hormone Receptor-positive HER2-negative Breast Cancer: Olaparib, Abemaciclib or Ribociclib - Which One, How and For Whom?

早期激素受体阳性 HER2 阴性乳腺癌的辅助靶向治疗:奥拉帕尼、阿贝西利或瑞博西尼——哪种、如何使用以及适用于哪些患者?

Lukac, Stefan; Pfister, Kerstin; Schäffler, Henning; Leinert, Elena; Fink, Angelina; Rack, Brigitte; Fink, Visnja; Janni, Wolfgang; Heublein, Sabine